技术文章

Neuronal Signal Transduction Mechanisms and Disease Research

Neuronal signaling is the fundamental process by which the central nervous system senses, transmits, integrates, and adaptively regulates information. Through synaptic release, receptor activation, ion channel opening, second messenger generation, and gene expression regulation, neurons convert external stimuli and intercellular information into changes in membrane potential, synaptic plasticity, neural development, and behavioral output.

 

Keywords: neuronal signaling; GPCR; Notch signaling pathway; ion channel; synaptic plasticity; glial cells; neural stem cells; central nervous system disease

 

1 Basic Logic of Neuronal Signal Transduction

1.1 Levels of Neuronal Signaling

Neuronal signal transduction is not a single pathway, but a network composed of membrane excitability, synaptic transmission, receptor signaling, intracellular cascades, and transcriptional regulation.

(1) Membrane potential level

Neurons generate resting membrane potentials and action potentials through transmembrane movement of ions such as sodium, potassium, calcium, and chloride. Voltage-gated sodium channels mediate the rapid rising phase of action potentials, voltage-gated potassium channels participate in repolarization and firing frequency regulation, and voltage-gated calcium channels connect electrical activity with neurotransmitter release.

(2) Synaptic transmission level

Presynaptic neurons release signaling molecules such as glutamate, GABA, dopamine, 5-HT, acetylcholine, histamine, and neuropeptides. After receptors on the postsynaptic membrane recognize these neurotransmitters, excitatory or inhibitory responses are generated. Synaptic signals can rapidly alter membrane potential and can also produce long-term changes in synaptic strength through second messengers.

(3) Intracellular signaling level

After GPCRs, receptor tyrosine kinases, ion channels, Notch, and other receptors are activated, they can further connect to pathways such as cAMP/PKA, PLC/Ca²⁺/PKC, MAPK/ERK, PI3K/AKT, CaMK, CREB, and NF-κB, affecting neuronal excitability, survival, differentiation, and plasticity.

(4) Transcriptional and fate level

Long-term neural activity can alter the expression of CREB, NFAT, MEF2, Notch effector molecules, and neurotrophic factor-related genes, thereby affecting neuronal maturation, axonal and dendritic growth, synaptic remodeling, neural stem cell differentiation, and adaptive or injury responses under disease conditions.

 

Table 1 Major Levels of Neuronal Signal Transduction

 

Signaling Level

Major Molecules or Structures

Biological Significance

Membrane potential regulation

Voltage-gated Na⁺/K⁺/Ca²⁺ channels, Cl⁻ channels

Generates action potentials and regulates neuronal excitability

Synaptic transmission

Glutamate, GABA, monoamine neurotransmitters, neuropeptides

Mediates information transmission between neurons

Receptor signaling

GPCRs, ionotropic receptors, Notch, Trk receptors

Converts extracellular stimuli into intracellular responses

Second messengers

cAMP, Ca²⁺, DAG, IP3

Amplifies neural signals and connects downstream effectors

Transcriptional regulation

CREB, NFAT, Notch effector molecules, BDNF

Regulates plasticity, differentiation, survival, and disease adaptation

 


Figure 1 Schematic diagram of neuronal synaptic receptors and intracellular signaling transduction

 

1.2 Coordination Between Neurons and Glial Cells

Information processing in the central nervous system is not completed by neurons alone. Astrocytes, microglia, oligodendrocytes, and neural stem cells all participate in signal regulation.

(1) Astrocytes

Astrocytes regulate glutamate clearance, potassium buffering, energy metabolism, and blood-brain barrier function. Their Ca²⁺ signaling can influence neurotransmitter homeostasis and synaptic activity.

(2) Microglia

Microglia are immune surveillance cells in the central nervous system. They can affect synaptic pruning, neuroinflammation, and neurodegenerative lesions through inflammatory factors, complement, and phagocytosis.

(3) Oligodendrocytes

Oligodendrocytes form myelin sheaths and improve neural conduction efficiency. Myelin injury alters the conduction velocity of nerve impulses and participates in multiple sclerosis, white matter injury, and neurodegenerative diseases.

(4) Neural stem cells

The proliferation, self-renewal, and differentiation of neural stem cells are regulated by signaling pathways such as Notch, Wnt, BMP, FGF, Shh, and neurotrophic factors. Notch signaling is especially closely associated with maintaining stem cells in an undifferentiated state and regulating neurogenesis.

 

2 GPCR-Mediated Neuronal Signaling

2.1 Localization of GPCRs in the Nervous System

G protein-coupled receptors (GPCRs) are one of the most important receptor families in the nervous system. 5-HT receptors, histamine receptors, opioid receptors, dopamine receptors, muscarinic acetylcholine receptors, adenosine receptors, and many neuropeptide receptors all belong to the GPCR family.

(1) Ligand recognition

GPCRs can recognize neurotransmitters, peptide ligands, lipid mediators, light signals, taste molecules, and metabolites. After activation, receptors undergo conformational changes and further regulate heterotrimeric G proteins.

(2) G protein branches

Gαs usually promotes cAMP generation, Gαi/o usually inhibits cAMP and regulates ion channels through Gβγ, Gαq/11 activates PLCβ and triggers Ca²⁺ and PKC signaling, and Gα12/13 is associated with RhoA and cytoskeletal regulation.

(3) Regulation of neuronal excitability

GPCRs can indirectly regulate voltage-gated calcium channels, potassium channels, TRP channels, and synaptic release mechanisms, thereby altering neuronal firing frequency, neurotransmitter release probability, and synaptic strength.

 

2.2 5-HT Receptor Signaling

(1) Mechanistic core

5-HT receptors participate in the regulation of mood, sleep, pain, appetite, gastrointestinal motility, and cognition. Most 5-HT receptors are GPCRs, and different subtypes can connect to Gαs, Gαi/o, or Gαq/11 pathways.

(2) Experimental indicators

Commonly detected indicators include cAMP, Ca²⁺, ERK phosphorylation, synaptic currents, neuronal firing frequency, receptor expression, and behavioral changes.

(3) Result interpretation

Although they are all 5-HT receptors, different subtypes may produce completely different effects. The receptor subtype should be clearly defined during research, and results should not be summarized simply as “enhanced or weakened 5-HT signaling.”

 

2.3 Opioid Receptor Signaling

(1) Mechanistic core

Opioid receptors mainly include μ, δ, and κ receptors. Most of them reduce cAMP levels through Gαi/o and regulate calcium channels and potassium channels through Gβγ. This signaling reduces neurotransmitter release and neuronal excitability and is an important mechanism in analgesia and addiction research.

(2) Experimental indicators

Commonly detected indicators include decreased cAMP, calcium channel inhibition, potassium channel opening, β-arrestin recruitment, receptor internalization, pain-related behavior, and reward-related behavior.

(3) Result interpretation

Opioid receptor research should not evaluate only analgesic effects; tolerance, dependence, respiratory depression, and β-arrestin-biased signaling should also be assessed. The bias of different ligands toward G protein pathways or β-arrestin pathways may determine differences in efficacy and adverse reactions.

 

2.4 Histamine Receptor Signaling

(1) Mechanistic core

Histamine receptors participate in wakefulness, allergic inflammation, gastric acid secretion, and neuroimmune regulation. H1 receptors commonly connect to Gαq/11-Ca²⁺ signaling, H2 receptors mostly connect to Gαs-cAMP signaling, and H3 receptors often act as presynaptic autoreceptors that regulate neurotransmitter release.

(2) Experimental indicators

Ca²⁺ transients, cAMP levels, neurotransmitter release, neuronal excitability, and inflammatory factor changes can be detected.

(3) Result interpretation

Histamine signaling shows marked cell type differences. Activation of presynaptic H3 receptors may reduce neurotransmitter release, whereas activation of postsynaptic receptors may alter neuronal excitability. Interpretation should therefore depend on receptor localization and subtype.

 

Table 2 Common GPCRs in the Nervous System and Their Signaling Characteristics

 

Receptor Type

Major Signaling Branches

Neural Functions

5-HT receptors

Gαs, Gαi/o, Gαq/11

Mood, sleep, pain, gastrointestinal motility, and cognition

Dopamine receptors

D1-like Gαs, D2-like Gαi/o

Reward, movement, psychiatric behavior, and endocrine regulation

Opioid receptors

Gαi/o, Gβγ

Analgesia, addiction, mood, and regulation of neurotransmitter release

Histamine receptors

Gαq/11, Gαs, Gαi/o

Wakefulness, inflammation, gastric acid secretion, and neuroimmunity

Adenosine receptors

Gαs or Gαi/o

Neuroprotection, sleep, inflammation, and synaptic regulation

mAChR

Gαq/11 or Gαi/o

Cognition, secretion, smooth muscle contraction, and neuronal excitability

 

3 Ion Channels and Neuronal Excitability

3.1 Voltage-Gated Sodium Channels

(1) Mechanistic core

Voltage-gated sodium channels are responsible for rapid depolarization during action potentials. After channel opening, Na⁺ rapidly flows inward, causing the membrane potential to rise quickly and initiating and propagating nerve impulses.

(2) Experimental indicators

Patch-clamp recording is commonly used to detect sodium currents, current density, activation/inactivation kinetics, and action potential threshold. Nav channel expression and mutations can also be detected.

(3) Result interpretation

Enhanced sodium channel function usually increases neuronal excitability and may be associated with epilepsy, pain, and some neurodevelopmental disorders. Reduced function may lead to conduction defects or insufficient neural function.

 

3.2 Voltage-Gated Calcium Channels

(1) Mechanistic core

Voltage-gated calcium channels connect membrane electrical activity with neurotransmitter release. When an action potential reaches the presynaptic terminal, Ca²⁺ influx triggers synaptic vesicle fusion and neurotransmitter release.

(2) Experimental indicators

Calcium currents, intracellular Ca²⁺ transients, synaptic vesicle release, synaptic currents, and calcium channel subtype expression are commonly detected.

(3) Result interpretation

Enhanced calcium channel function can increase neurotransmitter release and neuronal excitability, whereas reduced function may decrease synaptic transmission. GPCR-mediated inhibition of voltage-gated calcium channels through Gβγ is one of the important mechanisms of neuromodulation.

 

3.3 TRP Channels

(1) Mechanistic core

Transient receptor potential (TRP) channels can sense temperature, mechanical stimuli, chemical stimuli, osmotic pressure, and inflammatory mediators, and are especially important in sensory neurons. TRPV, TRPA, TRPM, and other subtypes participate in pain, inflammation, temperature sensation, and neural injury responses.

(2) Experimental indicators

Ca²⁺ influx, membrane currents, pain behavior, inflammatory factors, channel expression, and drug sensitivity are commonly detected.

(3) Result interpretation

TRP channel activation usually indicates enhanced sensory neuron excitability, but interpretation should take inflammatory status and cell type into account. If TRP channel expression increases together with reduced pain threshold, its participation in pain sensitization is supported.

 

3.4 Chloride Homeostasis and Inhibitory Signaling

(1) Mechanistic core

GABA_A receptors and glycine receptors mediate Cl⁻ channel opening. In mature neurons, KCC2 maintains a low intracellular Cl⁻ concentration, making GABA signaling mainly inhibitory. If Cl⁻ homeostasis is disrupted, GABA signaling may shift from inhibitory to depolarizing.

(2) Experimental indicators

GABA-evoked currents, KCC2, NKCC1, intracellular Cl⁻ levels, and inhibitory synaptic currents are commonly detected.

(3) Result interpretation

GABA receptor expression does not necessarily mean that inhibitory function is normal. If KCC2 decreases or NKCC1 increases, GABA signaling may weaken or even shift toward depolarization. This is important in epilepsy, neurodevelopmental abnormalities, and post-injury changes in excitability.

 

4 Notch Signaling and Neural Development

4.1 Basic Process of Notch Signaling

(1) Mechanistic core

Notch signaling is a development-regulating pathway dependent on cell-cell contact. After a ligand binds to the Notch receptor, the receptor undergoes proteolytic cleavage and releases the Notch intracellular domain (NICD), which then enters the nucleus and regulates target gene expression.

(2) Key molecules

Notch receptors, Delta/Jagged ligands, ADAM proteases, γ-secretase, RBPJ, and Hes/Hey transcription factors are important components of this pathway. γ-Secretase participates in both Notch receptor cleavage and APP processing, whereas β-secretase is mainly involved in APP processing and Aβ generation; therefore, neurodegenerative disease research should distinguish Notch signaling from APP/Aβ-related secretase processes.

(3) Functional significance

Notch signaling can regulate neural stem cell proliferation, survival, self-renewal, and differentiation, maintain the undifferentiated cell pool, and affect lineage selection among neurons, astrocytes, and oligodendrocytes.

 

4.2 Notch and Neural Stem Cells

(1) Mechanistic core

When Notch activity is high, neural stem cells are more likely to maintain an undifferentiated state. When Notch signaling decreases, cells are more likely to enter the neuronal differentiation program. This process is important for embryonic development, adult neurogenesis, and post-injury repair.

(2) Experimental indicators

NICD, Hes1, Hes5, Nestin, Sox2, DCX, NeuN, GFAP, Olig2, and cell proliferation indicators are commonly detected.

(3) Result interpretation

Enhanced Notch signaling does not necessarily indicate enhanced neural repair. Long-term excessive Notch activation may maintain stem cells in an undifferentiated state and inhibit neurogenesis. Excessive Notch reduction may lead to depletion of the stem cell pool.

 

4.3 Notch and Nervous System Diseases

(1) Stroke

After ischemia, Notch signaling can affect neural stem cell activation, vascular responses, inflammation, and glial cell responses. Notch may have different roles at different stages, so the acute phase and repair phase should be analyzed separately.

(2) Alzheimer’s disease

γ-Secretase participates in both Notch receptor cleavage and amyloid precursor protein processing. Therefore, targeting secretases in neurodegenerative diseases requires simultaneous consideration of Aβ production and Notch-related side effects.

(3) Central nervous system tumors

Notch signaling can maintain stem cell-like characteristics in some tumors and promote proliferation, drug resistance, and invasion. Research should combine cell proliferation, stemness markers, differentiation status, and tumor-forming capacity for interpretation.

 

Table 3 Research Focuses of Notch Signaling in the Nervous System

 

Research Direction

Major Molecules

Key Question

Neural stem cell maintenance

Notch, NICD, Hes1, Hes5

Whether undifferentiation and self-renewal are maintained

Neuronal differentiation

Sox2, DCX, NeuN

Whether Notch reduction promotes neurogenesis

Glial cell differentiation

GFAP, Olig2, MBP

Whether astrocyte or oligodendrocyte lineage selection is affected

Neurodegenerative diseases

γ-secretase, APP, Notch

How to balance Aβ production and Notch function

CNS tumors

Notch, Hes, stemness markers

Whether tumor stem cell-like states are maintained

 

5 Synaptic Plasticity and Intracellular Cascades

5.1 Ca²⁺/CaMK/CREB Pathway

(1) Mechanistic core

Ca²⁺ is the core second messenger that converts neuronal activity into intracellular responses. NMDA receptors, voltage-gated calcium channels, and some TRP channels can all cause Ca²⁺ elevation, further activating CaMK and CREB and regulating synaptic plasticity and gene expression.

(2) Experimental indicators

Intracellular Ca²⁺ transients, CaMKII phosphorylation, CREB phosphorylation, BDNF expression, dendritic spine density, and long-term potentiation (LTP) are commonly detected.

(3) Result interpretation

The significance of Ca²⁺ elevation depends on amplitude, duration, and spatial location. Transient local Ca²⁺ signals can promote synaptic plasticity, whereas sustained excessive Ca²⁺ may induce excitotoxicity and cell death.

 

5.2 MAPK/ERK Pathway

(1) Mechanistic core

The MAPK/ERK pathway can be activated by GPCRs, receptor tyrosine kinases, neurotrophic factors, and synaptic activity. It participates in neuronal differentiation, synaptic plasticity, memory formation, and cell survival.

(2) Experimental indicators

p-ERK, p-MEK, CREB, immediate early genes, neurite length, and synapse-related proteins are commonly detected.

(3) Result interpretation

Increased ERK phosphorylation should be interpreted according to the time point. Short-term activation may participate in signal transduction, whereas sustained abnormal activation may be associated with pathological excitation, inflammation, or tumor-like proliferation.

 

5.3 PI3K/AKT Pathway

(1) Mechanistic core

The PI3K/AKT pathway is related to neuronal survival, metabolic regulation, axonal growth, and anti-apoptotic responses. Neurotrophic factors, some GPCRs, and receptor tyrosine kinases can all activate this pathway.

(2) Experimental indicators

p-AKT, p-GSK3β, mTOR signaling, cell survival, neurite growth, and synaptic protein expression are commonly detected.

(3) Result interpretation

AKT activation is usually associated with enhanced survival signaling, but in tumor or abnormal proliferation contexts it may also promote pathological cell proliferation. In nervous system research, neuroprotection and abnormal proliferation should be distinguished according to cell type.

 

5.4 BDNF/TrkB Signaling

(1) Mechanistic core

After BDNF binds TrkB, it can activate the MAPK/ERK, PI3K/AKT, and PLCγ pathways, promoting neuronal survival, synaptic maturation, dendritic spine formation, and plasticity regulation.

(2) Experimental indicators

BDNF, TrkB phosphorylation, p-ERK, p-AKT, p-CREB, synaptic proteins, dendritic spine density, and behavioral learning and memory indicators are commonly detected.

(3) Result interpretation

Increased BDNF does not necessarily represent a purely protective effect. Depending on brain region, disease stage, and receptor status, BDNF may participate in compensatory repair or pathological excitation and epileptic sensitization.

 

6 Abnormal Neuronal Signaling and Disease

6.1 Epilepsy

(1) Mechanistic characteristics

Epilepsy is associated with excitation/inhibition imbalance, enhanced glutamatergic excitation, weakened GABAergic inhibition, ion channel abnormalities, Ca²⁺ overload, and neuroinflammation.

(2) Key indicators

NMDA/AMPA receptors, GABA_A receptors, KCC2, Nav channels, Ca²⁺ signaling, GFAP, Iba1, IL-1β, and TNF-α are commonly detected.

(3) Interpretation focus

Enhanced neuronal excitability should be judged together with electrophysiology, neurotransmitter receptors, ion channels, and behavioral seizures. Elevation of a single inflammatory factor cannot fully explain epileptogenesis.

 

6.2 Alzheimer’s Disease

(1) Mechanistic characteristics

Alzheimer’s disease involves Aβ, Tau pathology, synaptic injury, neuroinflammation, mitochondrial dysfunction, and abnormal neurotrophic signaling. γ-Secretase-related processes connect both Aβ production and Notch signaling, resulting in mechanistic complexity.

(2) Key indicators

Aβ, p-Tau, synaptic proteins, BDNF/TrkB, γ-secretase-related molecules, Notch/NICD, GFAP, Iba1, and cognitive behavior are commonly detected.

(3) Interpretation focus

Reducing Aβ is not necessarily equivalent to improving cognition. Synaptic function, neuroinflammation, neuronal survival, and behavioral results should be evaluated together.

 

6.3 Stroke and Ischemic Injury

(1) Mechanistic characteristics

After cerebral ischemia, insufficient energy supply leads to ion pump dysfunction, increased glutamate release, Ca²⁺ overload, oxidative stress, and inflammatory responses. Notch, PI3K/AKT, MAPK, and inflammatory pathways all participate in injury and repair processes.

(2) Key indicators

Infarct volume, neurological function score, Ca²⁺ signaling, ROS, cell death, inflammatory factors, Notch/NICD, neurogenesis, and angiogenesis indicators are commonly detected.

(3) Interpretation focus

Stroke research should distinguish the acute injury phase from the repair phase. In the acute phase, inhibiting excessive excitation and inflammation may be protective; in the recovery phase, neurogenesis, glial responses, and vascular remodeling should be emphasized.

 

6.4 Central Nervous System Tumors

(1) Mechanistic characteristics

Central nervous system tumors such as gliomas can use Notch, GPCR, PI3K/AKT, MAPK, and calcium signaling to maintain proliferation, invasion, stemness, and therapeutic tolerance.

(2) Key indicators

Notch/NICD, Hes1, GPCR expression, p-AKT, p-ERK, migration and invasion, tumor sphere formation, stemness markers, and therapeutic sensitivity are commonly detected.

(3) Interpretation focus

If only decreased proliferation is observed after targeting Notch or GPCRs, stemness, invasion, differentiation status, and in vivo tumor-forming capacity should be further confirmed to avoid misinterpreting general cytotoxicity as a specific pathway effect.

 

Table 4 Representative Products Related to Neuronal Signal Transduction

 

Research Module

Representative Product

CAS No.

Mechanism or Detection Positioning

Applicable Research

5-HT receptor signaling research

Serotonin hydrochloride

153-98-0

5-HT receptor ligand

5-HT receptor activation, cAMP/Ca²⁺ signaling, and mood- and pain-related mechanism research

Dopamine receptor research

Dopamine hydrochloride

62-31-7

Dopamine receptor ligand

D1/D2-like receptors, reward pathways, motor regulation, and cAMP signaling research

Histamine receptor research

Histamine dihydrochloride

56-92-8

Histamine receptor ligand

H1/H2/H3/H4 receptors, wakefulness, inflammation, and neuroimmune research

Cholinergic signaling research

Acetylcholine chloride

60-31-1

Acetylcholine receptor ligand

mAChR signaling, Ca²⁺ responses, cognition, secretion, and neuronal excitability research

Adenosine receptor research

Adenosine

58-61-7

Endogenous adenosine receptor ligand

Neuroprotection, sleep regulation, inflammation suppression, and synaptic modulation research

Inhibitory neurotransmitter research

γ-Aminobutyric acid (GABA)

56-12-2

GABA receptor ligand

Inhibitory synaptic transmission, excitation/inhibition balance, and epilepsy mechanism research

GPCR-cAMP pathway research

Forskolin

66575-29-9

Adenylyl cyclase activator that increases cAMP levels

Positive control for GPCR downstream cAMP/PKA/CREB signaling

cAMP degradation regulation research

IBMX

28822-58-4

Non-selective PDE inhibitor that enhances cAMP signaling

cAMP accumulation assays, GPCR pharmacology evaluation, and PDE-related regulation research

Ca²⁺ signal detection

Fluo-4 AM

273221-67-3

Ca²⁺ fluorescent probe

Calcium imaging, neuronal activity, and downstream Ca²⁺ detection for GPCRs/ion channels

Ca²⁺ signal detection

Fura-2 AM

108964-32-5

Ratiometric Ca²⁺ fluorescent probe

Intracellular Ca²⁺ dynamics, calcium channel function, and neuronal excitability research

Voltage-gated calcium channel research

Nifedipine

21829-25-4

L-type voltage-gated calcium channel blocker

Ca²⁺ influx, neurotransmitter release, and excitability regulation research

TRP channel research

Capsaicin

404-86-4

TRPV1 agonist

Pain sensitization, sensory neuron excitability, and inflammatory pain research

Glutamatergic excitatory signaling research

NMDA

6384-92-5

NMDA receptor agonist

Excitatory synaptic transmission, Ca²⁺ influx, LTP, and excitotoxicity research

Epilepsy/excitotoxicity model

Kainic acid

487-79-6

Kainate receptor/ionotropic glutamate receptor agonist

Epilepsy models, excitotoxicity, neuronal injury, and inflammatory response research

Notch signaling inhibition research

DAPT

208255-80-5

γ-secretase inhibitor that inhibits Notch receptor cleavage

Notch/NICD signaling, neural stem cell differentiation, and CNS tumor research

MAPK/ERK pathway research

U0126

109511-58-2

MEK inhibitor that blocks ERK activation

p-ERK signaling, synaptic plasticity, neural differentiation, and tumor signaling validation

PI3K/AKT pathway research

LY294002

154447-36-6

PI3K inhibitor

p-AKT signaling, neuronal survival, axonal growth, and tumor-related pathway research

 

Table 5 Product Lines Related to Neural Signaling Pathways and Application Directions

 

Research Direction

Product Line

Covered Object/Target

Applicable Research Direction

5-HT signaling research

5-HT Receptor

 

5-HT receptor subtypes and related regulatory molecules

Mood, sleep, pain, gastrointestinal motility, cognition, and CNS drug research

Dopamine signaling research

Dopamine Receptor

 

D1-like and D2-like dopamine receptors

Reward pathways, motor regulation, psychiatric behavior, addiction, and neuropsychiatric disease research

Dopamine transport research

Dopamine Transporter

 

DAT and dopamine reuptake-related targets

Dopamine homeostasis, addiction, Parkinson’s disease, psychiatric diseases, and transporter pharmacology research

5-HT transport research

Serotonin Transporter

 

SERT and 5-HT reuptake-related targets

Depression, anxiety, mood regulation, antidepressants, and monoamine neurotransmitter homeostasis research

Acetylcholine receptor research

mAChR

 

Muscarinic acetylcholine receptors

Cognition, secretion, smooth muscle contraction, cholinergic neural regulation, and GPCR signaling research

Acetylcholine receptor research

nAChR

 

Nicotinic acetylcholine receptors

Fast synaptic transmission, neuromuscular junction, addiction, cognition, and ion channel research

Choline metabolism research

Cholinesterase (ChE)

 

Acetylcholinesterase and cholinesterase-related targets

Cholinergic neurotransmitter metabolism, Alzheimer’s disease, neurotoxicity, and enzyme inhibitor research

Monoamine metabolism research

Monoamine Oxidase

 

MAO-A and MAO-B

Dopamine/5-HT/norepinephrine metabolism, Parkinson’s disease, depression, and neuroprotection research

Catecholamine metabolism research

COMT

 

Catechol-O-methyltransferase

Dopamine metabolism, cognition, psychiatric diseases, Parkinson’s disease, and monoamine signaling research

GABAergic signaling research

GABA Receptor

 

GABA_A, GABA_B, and related receptors

Inhibitory synaptic transmission, epilepsy, anxiety, sleep, and neuronal excitability regulation research

Glutamate receptor research

iGluR

 

NMDA, AMPA, kainate, and other ionotropic glutamate receptors

Excitatory synaptic transmission, LTP/LTD, excitotoxicity, and neurodegenerative disease research

Glutamate receptor research

mGluR

 

Metabotropic glutamate receptors

GPCR-type glutamate signaling, synaptic plasticity, epilepsy, pain, and neuropsychiatric disease research

Glycine transport research

GlyT

 

Glycine transporters

Inhibitory transmission, NMDA co-agonist regulation, pain, and psychiatric disease research

Histamine signaling research

Histamine Receptor

 

H1, H2, H3, H4, and other histamine receptors

Wakefulness, allergic inflammation, gastric acid secretion, neuroimmunity, and neuromodulation research

Adenosine signaling research

Adenosine Kinase

 

Adenosine metabolism and adenosine kinase-related targets

Adenosine homeostasis, neuroprotection, epilepsy, inflammation, and energy metabolism research

Adrenergic signaling research

Adrenergic Receptor

 

α/β-adrenergic receptors

Sympathetic regulation, stress response, cardiovascular function, metabolism, and neuronal excitability research

Opioid system research

Opioid Receptor

 

μ, δ, κ, and other opioid receptors

Analgesia, addiction, mood regulation, Gi/o signaling, tolerance, and biased ligand research

Cannabinoid system research

Cannabinoid Receptor

 

CB1 and CB2 receptors

Pain, neuroinflammation, synaptic release, metabolism, and immune regulation research

Endocannabinoid metabolism research

FAAH

 

Fatty acid amide hydrolase

Endocannabinoid degradation, pain, anxiety, inflammation, and neuroprotection research

Neuropeptide signaling research

Neurokinin Receptor

 

NK receptor family

Pain, inflammation, emesis responses, smooth muscle contraction, and neuropeptide signaling research

Neuropeptide signaling research

Neuropeptide Y Receptor

 

NPY receptor family

Appetite, energy metabolism, anxiety, vascular regulation, and neuroendocrine research

Neuropeptide signaling research

Neurotensin Receptor

 

Neurotensin receptors

Dopamine regulation, pain, gastrointestinal function, tumor signaling, and neural modulation research

Neuropeptide signaling research

CGRP Receptor

 

CGRP receptor complex

Migraine, pain transmission, vasodilation, and neuroinflammation research

Appetite and wakefulness research

Orexin Receptor (OX Receptor)

 

Orexin receptors

Sleep-wake regulation, appetite, energy metabolism, and central neural regulation research

Appetite and metabolism research

MCHR1 (GPR24)

 

Melanin-concentrating hormone receptor

Appetite, energy metabolism, mood, and neuroendocrine research

Melanocortin signaling research

Melanocortin Receptor

 

MC receptor family

Appetite, energy metabolism, pigmentation, inflammation, and endocrine regulation research

Sleep rhythm research

Melatonin Receptor

 

MT1 and MT2 receptors

Circadian rhythm, sleep, neuroendocrine regulation, and oxidative stress-related research

Gastrointestinal neuropeptide research

Cholecystokinin Receptor

 

CCK receptors

Gastrointestinal secretion, gallbladder contraction, appetite regulation, and neuroendocrine research

Metabolic GPCR research

GPR119

 

Lipid metabolite-sensing GPCR

Insulin secretion, incretin release, glucose metabolism, and metabolism-neural regulation research

Orphan GPCR research

GPR139

 

CNS-related orphan GPCR

Neural regulation, behavior, metabolic sensing, ligand screening, and CNS function research

Lipid-sensing GPCR research

GPR55

 

Lipid-sensing GPCR

Neuroinflammation, pain, bone metabolism, tumor migration, and cannabinoid-related signaling research

Sigma signaling research

Sigma Receptor

 

Sigma-1/Sigma-2-related targets

Neuroprotection, pain, psychiatric diseases, ER stress, and neurodegenerative disease research

Imidazoline signaling research

Imidazoline Receptor

 

I1, I2, and I3-related receptors

Blood pressure regulation, pain, metabolism, neuroprotection, and central regulation research

Calcium signaling research

Calcium Channel

 

Voltage-gated calcium channels and related subtypes

Synaptic release, neuronal excitability, pain, epilepsy, and calcium signaling pharmacology research

TRP channel research

TRP Channel

 

TRPV, TRPA, TRPM, and other TRP channels

Pain, temperature sensation, inflammation, sensory neuron excitability, and Ca²⁺ influx research

Ca²⁺/CaMK signaling research

CaMK

 

CaMK family, especially CaMKII-related targets

Synaptic plasticity, LTP, CREB activation, memory formation, and excitotoxicity research

Ca²⁺-dependent phosphatase research

Calcineurin

 

Calcineurin-related targets

Ca²⁺-dependent transcription, NFAT signaling, synaptic plasticity, and neurodegenerative lesions research

Neurotrophic signaling research

Trk Receptor

 

TrkA, TrkB, and TrkC receptors

BDNF/NGF/NT-3 signaling, neuronal survival, axonal growth, and synaptic maturation research

Notch developmental signaling research

Notch

 

Notch receptors, NICD, and related regulatory molecules

Neural stem cell maintenance, self-renewal, differentiation, glial lineage selection, and CNS tumor research

β-secretase research

Beta-secretase

 

BACE-related targets

APP processing, Aβ generation, Alzheimer’s disease, and neurodegenerative disease research

γ-secretase research

γ-secretase

 

γ-secretase complex and substrate processing

Notch cleavage, APP processing, Aβ generation, and secretase-targeted intervention research

Aβ pathology research

Amyloid-β

 

Aβ generation, aggregation, and toxicity-related targets

Alzheimer’s disease, synaptic injury, neuroinflammation, and cognitive impairment research

Tau pathology research

Tau Protein

 

Tau phosphorylation, aggregation, and neurofibrillary tangle-related targets

Alzheimer’s disease, tauopathy, axonal function, and neurodegenerative lesions research

α-Synuclein research

α-synuclein

 

α-synuclein aggregation and toxicity-related targets

Parkinson’s disease, Lewy body disease, synaptic function, and protein aggregation research

Parkinson’s disease pathway research

PINK1/Parkin

 

Mitochondrial quality control and mitophagy-related targets

Parkinson’s disease, mitochondrial injury, neuronal survival, and oxidative stress research

Huntington’s disease research

Huntingtin

 

Mutant HTT protein and related pathological processes

Huntington’s disease, protein aggregation, transcriptional abnormalities, and neuronal degeneration research

TTR-related neuropathy research

Transthyretin (TTR)

 

TTR and amyloidosis-related targets

TTR amyloidosis, peripheral neuropathy, and protein stability research

Glycosylation regulation research

OGT

 

O-GlcNAc transferase

Neuronal protein O-GlcNAc modification, stress, Tau regulation, and metabolism-neural signaling research

Deglycosylation regulation research

OGA

 

O-GlcNAcase

O-GlcNAc removal, Tau pathology, neurodegenerative diseases, and stress response research

Ceramide metabolism research

Glucosylceramide Synthase (GCS)

 

Glycosphingolipid synthesis-related targets

Neurodegenerative diseases, lysosomal function, lipid metabolism, and neuroinflammation research

Autophagy/endocytosis regulation research

AAK1

 

AP2-associated kinase and endocytosis-related targets

Receptor endocytosis, synaptic vesicle cycling, neuroinflammation, and neurodegenerative disease research

Lysosomal protease research

Legumain

 

Asparagine endopeptidase-related targets

Protein degradation, neurodegenerative lesions, inflammation, and Tau/Aβ-related pathology research

Neurodevelopmental transcriptional regulation research

OLIG2

 

Oligodendrocyte lineage transcription factor

Oligodendrocyte differentiation, myelination, neurodevelopment, and CNS tumor research

Sensory receptor research

Olfactory Receptor

 

Olfactory receptor-related GPCRs

Olfactory signaling, sensory neuron function, ectopic expression, and neural regulation research

 

The core of neuronal signal transduction is to correlate receptor recognition, ion channel activity, second messenger changes, intracellular cascades, and cell type-specific outcomes. GPCR and Notch signaling represent important directions in neuromodulation and developmental fate regulation, respectively. Together with ion channels, synaptic plasticity, glial responses, and neural stem cell states, they determine central nervous system development, homeostasis, and disease progression.

 

References

[1] Palczewski K, et al. Annu Rev Neurosci. 2013 Jul 8;36:139-164.

[2] Geppetti P, et al. Neuron. 2015 Nov 18;88(4):635-649.

 

For more related articles, please see below:

[1] Ras-Raf-MEK-ERK Signaling

[2] Wnt/β-Catenin Signaling Pathway

[3] How to Map the NF-κB Pathway and Choose Inhibitors: Bringing Inflammatory Transcriptional Output into a “Controllable Range” (Tables A–F)

[4] Metabolic signaling pathway

[5] Wnt Signaling

[6] Hedgehog Signaling

[7] JAK-STAT Cell Signaling Pathway

[8] PD-1/PD-L1 Signaling Pathway

[9] Granzyme A and Granzyme B Signaling Pathways: Cytotoxic Effects and Immune Regulatory Mechanisms

[10] CTLA4 Signaling Pathway: Molecular Basis, Immunoregulatory Mechanisms, and Disease Associations

[11] VEGF Signaling Pathway: Receptor Lineage, Activation Mechanisms, and Biological Effects

[12] Applications of BMP Signaling Pathway Regulators in Stem Cell Differentiation, Organoid Culture and Developmental Research

[13] TNF Signaling Pathway: Receptor Layering Structure, Complex Conversion Mechanisms, and the Inflammation–Death Effector Network

[14] RANK Signaling Pathway: Molecular Components, Activation Mechanisms, and Biological Effects

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Neuronal Signal Transduction Mechanisms and Disease Research》. 阿拉丁知识库,更新于 2026年7月29日。 https://www.aladdin-e.com/zh_cn/faqs/neuronal-signal-transduction-mechanisms-and-disease-research-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助